Tag: amidst

As the Q4 FY24 earnings season is going on, Goldman Sachs (NYSE:GS) analysts have recalibrated their projections for the Indian pharmaceutical sector, factoring in a spectrum of variables from monthly sales data to currency fluctuations. Notably, the sector continues to trade at valuations exceeding one standard deviation above its five-year average, largely propelled by the resilience of major players like Sun Pharma (NS:SUN), Cipla (NS:CIPL), and Divi’s Laboratories.

Guaranty Bancshares, Inc. (NYSE:GNTY), a Texas-based banking institution, reported a solid first quarter for 2024, despite taking a conservative approach to its balance sheet due to economic uncertainties. The bank saw a slight decrease in total assets and liabilities, with a strategic decision to shrink its balance sheet.